HUTCHMED (China) (HCM) Non-Current Assets (2015 - 2025)
HUTCHMED (China)'s (HCM) quarterly Non-Current Assets came in at $66.1 million in Q4 2025, down 2.15% year-on-year from $67.6 million in Q4 2024, and down 63.99% on a QoQ basis from $183.6 million in Q2 2025.
HUTCHMED (China) (HCM) Non-Current Assets (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Non-Current Assets data on file, last reported at $66.1 million in Q4 2025.
- On a quarterly basis, Non-Current Assets fell 2.15% year-over-year to $66.1 million in Q4 2025; TTM through Dec 2025 was $66.1 million, a 2.15% decrease from a year earlier, with the FY2025 full-year figure at $66.1 million, down 2.15% from the prior year.
- Non-Current Assets for Q4 2025 stood at $66.1 million, down from $183.6 million in the prior quarter.
- Over the last five years, Non-Current Assets for HCM reached as high as $212.6 million in Q2 2024 and fell as low as $66.1 million in Q4 2025.
- Historically, Non-Current Assets has averaged $139.4 million across 5 years, with a median of $172.1 million in 2022.
- Across the five-year window, Non-Current Assets surged 98.75% in 2021 and fell 13.64% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $91.6 million in 2021, then slipped by 12.6% to $80.1 million in 2022, then retreated by 7.65% to $73.9 million in 2023, then declined by 8.63% to $67.6 million in 2024, then fell by 2.15% to $66.1 million in 2025.
- Per Business Quant data, the three most recent Non-Current Assets figures were $66.1 million in Q4 2025, $183.6 million in Q2 2025, and $67.6 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | 66.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 66.11 Mn |
| Jun 30, 2025 | 183.61 Mn |
| Dec 31, 2024 | 67.56 Mn |
| Jun 30, 2024 | 212.61 Mn |
| Dec 31, 2023 | 73.94 Mn |
| Jun 30, 2023 | 207.01 Mn |
| Dec 31, 2022 | 80.06 Mn |
| Jun 30, 2022 | 172.10 Mn |
| Dec 31, 2021 | 91.61 Mn |
| Jun 30, 2021 | 181.72 Mn |
| Mar 31, 2021 | 196.89 Mn |
| Dec 31, 2020 | 93.36 Mn |
| Jun 30, 2020 | 91.43 Mn |
| Dec 31, 2019 | 95.10 Mn |
| Sep 30, 2019 | 177.01 Mn |
| Jun 30, 2019 | 185.72 Mn |
| Mar 31, 2019 | 189.30 Mn |
| Dec 31, 2018 | 161.58 Mn |
| Jun 30, 2018 | 183.27 Mn |
| Dec 31, 2017 | 107.23 Mn |